Valance Washington/LinkedIn; Taras Oleksyk/EEBG; Walter Wolfsberger/The Oakland Post
Feb 9, 2026, 14:22
Valance Washington: An Evidence-Based View on Emerging Therapies for Thrombotic Disorders
Valance Washington, Professor at Oakland University, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”Our latest publication — a letter in the Journal of Thrombosis and Thrombolysis offering an evidence-based view on emerging therapies for thrombotic disorders.
A quick read for clinicians and researchers navigating these challenges.”
Title: Subject: letter to the editor: platelet single-cell RNA sequencing
Authors: Valance Washington, Walter Wolfsberger, Taras Oleksyk
Read the Full Article on Journal of Thrombosis and Thrombolysis
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 7, 2026, 23:20Balaji Balagani: Exploring Pulmonary Embolism
-
Jul 7, 2026, 23:03Roxana González Mazarío: The Phenotype-Specific Cardiovascular Risks in AAV
-
Jul 7, 2026, 22:52Harry Spoelstra: LongC0VID Still has Zero Proven Treatments
-
Jul 7, 2026, 22:39Satya K. Morar: Acute Portal Vein Thrombosis as an Exceptionally Rare Complication of Liver Biopsy in CVID
-
Jul 7, 2026, 22:23Aravind Palraj: Antiphospholipid Syndrome is not Just ‘Start Warfarin and Follow INR’
-
Jul 7, 2026, 20:59William Aird: An Unlucky Turn Into the Renal Artery
-
Jul 7, 2026, 20:58Chokri Ben Lamine: The Two-Hit Model of TRALI
-
Jul 7, 2026, 20:57New Issue of Blood Out Now – Blood Journals Portfolio
-
Jul 7, 2026, 20:56Priyadarshini Ramakrishnan: Schistocytes – The Most “Misleading Heroes” in a Peripheral Smear